169 related articles for article (PubMed ID: 20558616)
1. The cell polarity PTK7 receptor acts as a modulator of the chemotherapeutic response in acute myeloid leukemia and impairs clinical outcome.
Prebet T; Lhoumeau AC; Arnoulet C; Aulas A; Marchetto S; Audebert S; Puppo F; Chabannon C; Sainty D; Santoni MJ; Sebbagh M; Summerour V; Huon Y; Shin WS; Lee ST; Esterni B; Vey N; Borg JP
Blood; 2010 Sep; 116(13):2315-23. PubMed ID: 20558616
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the Promigratory and Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical Outcome in Colorectal Cancer.
Lhoumeau AC; Martinez S; Boher JM; Monges G; Castellano R; Goubard A; Doremus M; Poizat F; Lelong B; de Chaisemartin C; Bardin F; Viens P; Raoul JL; Prebet T; Aurrand-Lions M; Borg JP; Gonçalves A
PLoS One; 2015; 10(5):e0123768. PubMed ID: 25962058
[TBL] [Abstract][Full Text] [Related]
3. c-Jun N-terminal kinase activation failure is a new mechanism of anthracycline resistance in acute myeloid leukemia.
Lagadinou ED; Ziros PG; Tsopra OA; Dimas K; Kokkinou D; Thanopoulou E; Karakantza M; Pantazis P; Spyridonidis A; Zoumbos NC
Leukemia; 2008 Oct; 22(10):1899-908. PubMed ID: 18650843
[TBL] [Abstract][Full Text] [Related]
4. The Wnt/planar cell polarity protein-tyrosine kinase-7 (PTK7) is a highly efficient proteolytic target of membrane type-1 matrix metalloproteinase: implications in cancer and embryogenesis.
Golubkov VS; Chekanov AV; Cieplak P; Aleshin AE; Chernov AV; Zhu W; Radichev IA; Zhang D; Dong PD; Strongin AY
J Biol Chem; 2010 Nov; 285(46):35740-9. PubMed ID: 20837484
[TBL] [Abstract][Full Text] [Related]
5. Comparative integromics on non-canonical WNT or planar cell polarity signaling molecules: transcriptional mechanism of PTK7 in colorectal cancer and that of SEMA6A in undifferentiated ES cells.
Katoh M; Katoh M
Int J Mol Med; 2007 Sep; 20(3):405-9. PubMed ID: 17671748
[TBL] [Abstract][Full Text] [Related]
6. High TRAIL-R3 expression on leukemic blasts is associated with poor outcome and induces apoptosis-resistance which can be overcome by targeting TRAIL-R2.
Chamuleau ME; Ossenkoppele GJ; van Rhenen A; van Dreunen L; Jirka SM; Zevenbergen A; Schuurhuis GJ; van de Loosdrecht AA
Leuk Res; 2011 Jun; 35(6):741-9. PubMed ID: 21281967
[TBL] [Abstract][Full Text] [Related]
7. Soluble PTK7 inhibits tube formation, migration, and invasion of endothelial cells and angiogenesis.
Shin WS; Maeng YS; Jung JW; Min JK; Kwon YG; Lee ST
Biochem Biophys Res Commun; 2008 Jul; 371(4):793-8. PubMed ID: 18471990
[TBL] [Abstract][Full Text] [Related]
8. TWIST-1 promotes cell growth, drug resistance and progenitor clonogenic capacities in myeloid leukemia and is a novel poor prognostic factor in acute myeloid leukemia.
Wang N; Guo D; Zhao YY; Dong CY; Liu XY; Yang BX; Wang SW; Wang L; Liu QG; Ren Q; Lin YM; Ma XT
Oncotarget; 2015 Aug; 6(25):20977-92. PubMed ID: 26023795
[TBL] [Abstract][Full Text] [Related]
9. The cytosolic domain of protein-tyrosine kinase 7 (PTK7), generated from sequential cleavage by a disintegrin and metalloprotease 17 (ADAM17) and γ-secretase, enhances cell proliferation and migration in colon cancer cells.
Na HW; Shin WS; Ludwig A; Lee ST
J Biol Chem; 2012 Jul; 287(30):25001-9. PubMed ID: 22665490
[TBL] [Abstract][Full Text] [Related]
10. Silencing of PTK7 in colon cancer cells: caspase-10-dependent apoptosis via mitochondrial pathway.
Meng L; Sefah K; O'Donoghue MB; Zhu G; Shangguan D; Noorali A; Chen Y; Zhou L; Tan W
PLoS One; 2010 Nov; 5(11):e14018. PubMed ID: 21103379
[TBL] [Abstract][Full Text] [Related]
11. Induction of the proapoptotic tumor suppressor gene Cell Adhesion Molecule 1 by chemotherapeutic agents is repressed in therapy resistant acute myeloid leukemia.
Fisser MC; Rommer A; Steinleitner K; Heller G; Herbst F; Wiese M; Glimm H; Sill H; Wieser R
Mol Carcinog; 2015 Dec; 54(12):1815-9. PubMed ID: 25491945
[TBL] [Abstract][Full Text] [Related]
12. The Increased PTK7 Expression Is a Malignant Factor in Cervical Cancer.
Sun JJ; Li HL; Guo SJ; Ma H; Liu SJ; Liu D; Xue FX
Dis Markers; 2019; 2019():5380197. PubMed ID: 30944666
[TBL] [Abstract][Full Text] [Related]
13. Targeted inhibition of ULK1 enhances daunorubicin sensitivity in acute myeloid leukemia.
Qiu L; Zhou G; Cao S
Life Sci; 2020 Feb; 243():117234. PubMed ID: 31887299
[TBL] [Abstract][Full Text] [Related]
14. PTK7 expression in triple-negative breast cancer.
Ataseven B; Angerer R; Kates R; Gunesch A; Knyazev P; Högel B; Becker C; Eiermann W; Harbeck N
Anticancer Res; 2013 Sep; 33(9):3759-63. PubMed ID: 24023307
[TBL] [Abstract][Full Text] [Related]
15. PTK7 is a novel oncogenic target for esophageal squamous cell carcinoma.
Liu K; Song G; Zhang X; Li Q; Zhao Y; Zhou Y; Xiong R; Hu X; Tang Z; Feng G
World J Surg Oncol; 2017 May; 15(1):105. PubMed ID: 28545451
[TBL] [Abstract][Full Text] [Related]
16. PTK7 localization and protein stability is affected by canonical Wnt ligands.
Berger H; Breuer M; Peradziryi H; Podleschny M; Jacob R; Borchers A
J Cell Sci; 2017 Jun; 130(11):1890-1903. PubMed ID: 28420671
[TBL] [Abstract][Full Text] [Related]
17. IGFBP7 induces apoptosis of acute myeloid leukemia cells and synergizes with chemotherapy in suppression of leukemia cell survival.
Verhagen HJ; de Leeuw DC; Roemer MG; Denkers F; Pouwels W; Rutten A; Celie PH; Ossenkoppele GJ; Schuurhuis GJ; Smit L
Cell Death Dis; 2014 Jun; 5(6):e1300. PubMed ID: 24967962
[TBL] [Abstract][Full Text] [Related]
18. The PTK7 and ROR2 Protein Receptors Interact in the Vertebrate WNT/Planar Cell Polarity (PCP) Pathway.
Martinez S; Scerbo P; Giordano M; Daulat AM; Lhoumeau AC; Thomé V; Kodjabachian L; Borg JP
J Biol Chem; 2015 Dec; 290(51):30562-72. PubMed ID: 26499793
[TBL] [Abstract][Full Text] [Related]
19. Potential relation of aberrant proteolysis of human protein tyrosine kinase 7 (PTK7) chuzhoi by membrane type 1 matrix metalloproteinase (MT1-MMP) to congenital defects.
Golubkov VS; Aleshin AE; Strongin AY
J Biol Chem; 2011 Jun; 286(23):20970-6. PubMed ID: 21518755
[TBL] [Abstract][Full Text] [Related]
20. Catalytically inactive receptor tyrosine kinase PTK7 activates FGFR1 independent of FGF.
Shin WS; Lee HW; Lee ST
FASEB J; 2019 Nov; 33(11):12960-12971. PubMed ID: 31490704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
